Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 31 AL 45

Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease

de Sousa NF, Scotti L, de Moura ÉP, Dos Santos Maia M, Rodrigues GCS, de Medeiros HIR, Lopes SM, Scotti MT.

Curr Neuropharmacol. 2022;20(5):857-885. doi: 10.2174/1570159X19666211005145952.

Meta-analysis of the Connection Between Alzheimer Disease and Telomeres

Fu J, Ji X, Liu J, Chen X, Shang H.

Alzheimer Dis Assoc Disord. 2022 Jan-Mar 01;36(1):73-79. doi: 10.1097/WAD.0000000000000468.

A Review on the In Vitro Evaluation of the Anticholinesterase Activity Based on Ellman's Method

de Almeida RBM, de Almeida Luz RLS, Leite FHA, Botura MB.

Mini Rev Med Chem. 2022;22(13):1803-1813. doi: 10.2174/1389557521666211027104638.

Astrocyte Reactivity in Alzheimer's Disease: Therapeutic Opportunities to Promote Repair

Mirzaei N, Davis N, Chau TW, Sastre M.

Curr Alzheimer Res. 2022;19(1):1-15. doi: 10.2174/1567205018666211029164106.

What is the role of microbial infection in Alzheimer's disease?

Barichello T, Giridharan VV, Comim CM, Morales R.

Braz J Psychiatry. 2022 May-Jun;44(3):245-247. doi: 10.1590/1516-4446-2021-0037.

Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms

Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P.

Curr Top Behav Neurosci. 2022;56:287-317. doi: 10.1007/7854_2021_267.

Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links

Pakdin M, Toutounchian S, Namazi S, Arabpour Z, Pouladi A, Afsahi S, Poudineh M, Nasab MMM, Yaghoobpoor S, Deravi N.

Curr Diabetes Rev. 2022;18(8):e051121197760. doi: 10.2174/1573399818666211105122545.

Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration

Durai P, Beeraka NM, Ramachandrappa HVP, Krishnan P, Gudur P, Raghavendra NM, Ravanappa PKB.

Curr Neuropharmacol. 2022;20(5):893-915. doi: 10.2174/1570159X19666211109141330.

The Hybrid Compounds as Multi-target Ligands for the Treatment of Alzheimer's Disease: Considerations on Donepezil

Gulcan HO, Kosar M.

Curr Top Med Chem. 2022 Mar 4;22(5):395-407. doi: 10.2174/1568026621666211111153626.

Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San

Fu X, Liu Q, Sun X, Chang H, Liu Y, Han J.

J Alzheimers Dis. 2022;85(1):7-19. doi: 10.3233/JAD-210656.

A Comprehensive Review on Medicinal Herbs and Novel Formulations for the Prevention of Alzheimer's Disease

Singh B, Singh H, Singh B, Kumar N, Rajput A, Sidhu D, Kaur A, Arora S, Kaur S.

Curr Drug Deliv. 2022;19(2):212-228. doi: 10.2174/1567201818666211015152733.

A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer's Disease

Kumar M, Bansal N.

Curr Drug Targets. 2022;23(5):486-512. doi: 10.2174/1389450122666211118125233.

Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies

Kurz C, Walker L, Rauchmann BS, Perneczky R.

Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12782. doi: 10.1111/nan.12782. Epub 2022 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias